Skip to main content
Clinical Trials/NCT04948632
NCT04948632
Completed
Not Applicable

A Medico-Economic Evaluation of a Telehealth Platform for Elective Outpatient Surgeries: a Trial Study

Centre hospitalier de l'Université de Montréal (CHUM)1 site in 1 country1,000 target enrollmentJanuary 21, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Surgery--Complications
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Enrollment
1000
Locations
1
Primary Endpoint
Cost-effectiveness analysis of the LeoMed® telecare platform
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

The main objective of this study is to carry out a medico-economic evaluation of a new platform for outpatient surgical care, by comparing the effectiveness and utility of the deployment of this trajectory on patients and the health system to a control group.

Detailed Description

Outpatient surgery allows the patient to leave the hospital on the day of their surgery and thus avoid complete hospitalization. There are many advantages to this practice. Patients can remain in the comfort of their own home with the support of their family caregivers and the healthcare system can avoid incurring additional hospital costs and redirect these savings to other critical needs. However, despite the advantages of outpatient surgery, the tools and measures currently in place to supervise the preparation before the operation and the follow-up after the operation are suboptimal. Following surgery, adverse events such as moderate to severe pain, nausea/vomiting, infection and bleeding from the operative site are very rarely sought out and detected by healthcare facilities. However, these are the main causes of readmissions or emergency consultations for patients. In order to optimize the care offer, the anesthesiology department, the innovation and artificial intelligence center of the CHUM as well as the Quebec telecare platform LeoMed have joined forces in order to offer, through a health application, follow-up and personalized support for patients undergoing outpatient surgery. The investigators believe that the integration of this platform in the course of care will allow early diagnosis of the main postoperative complications and therefore, prevent calls to the Health-Info line, emergency room returns, as well as readmissions or unscheduled postoperative consultations. A patient-as-partner approach has been chosen in the initial phase, where 12 patients having had an outpatient surgery less than 6 months ago, will be recruited to test the platform. Another 12 patients, scheduled to undergo an outpatient surgery, will test the optimized support and follow up application. Their feedback will help to correct and/or improve the platform, if necessary.

Registry
clinicaltrials.gov
Start Date
January 21, 2022
End Date
February 28, 2024
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years old undergoing elective outpatient surgery under general or regional anesthesia
  • Internet access for the patient or their caregiver from home
  • Written, oral and spoken comprehension of French or English

Exclusion Criteria

  • Patient's or caregiver's inability to learn and use digital technologies
  • Conversion of outpatient to inpatient hospitalization on the day of surgery
  • Patient's refusal.

Outcomes

Primary Outcomes

Cost-effectiveness analysis of the LeoMed® telecare platform

Time Frame: 1 month after the surgery

The cost-effectiveness of the telecare platform deployment will be evaluated by the assessment of direct costs. These costs include unanticipated cancellations of the surgery on the day of surgery, calls at the CHUM local health info line, calls at the Quebec health info line (811), visits to the emergency department, unplanned readmissions or medical visits (family physician or outpatient clinic) for a problem related to the procedure.

Secondary Outcomes

  • Cost-utility analysis of the LeoMed® telecare platform(Change between baseline (pre-operative) and 1 month postoperative)
  • Patient satisfaction(1 month after the surgery)

Study Sites (1)

Loading locations...

Similar Trials